Effects of hexapeptide on human platelet aggregation activity

LONG Li-hui,GUO Qing,HAN Xu-liang,JIAN Liang,MI Yan-ni,CAO Yong-xiao

2013-01-01

Abstract:AIM This study aimed to investigate the anti-aggregation effects of hexapeptide on human platelets.METHODS Venous blood of healthy volunteer was taken,and was made into anticoagulation blood with sodium citrate,divided into control group,hexapeptide groups(1 × 10-9-1 × 10-5 mol.L-1) and four kinds of positive groups,including clopidogrel group(3 × 10-5mol.L-1),dipyridamole group(2 × 10-6mol.L-1),aspirin group(2.8 × 10-4 mol.L-1) and eptifibatide group(1 × 10-6 mol.L-1).Each group included 6 samples.The inducers were adenosine diphosphate(ADP) + adrenalin,arachidonic acid and thrombin,respectively.The human platelet aggregation rates induced by different inducers were determined with the method of turbidimetry.RESULTS The aggregation inhibition rates of 1 × 10-6 mol.L-1 hexapeptide in human induced by ADP,arachidonic acid and thrombin,were(98.81 ± 2.25) %,(94.58 ± 0.73) % and(33.46 ± 5.56) % respectively,and which were all significant higher than the control group(P < 0.01).Induced by ADP,the anti-platelet aggregation activity of 1 × 10-6 mol.L-1 hexapeptide was significant higher than that of clopidogrel,dipyridamole or aspirin(P < 0.01),but had no different with eptifibatide(P > 0.05).The anti-aggregation IC 50 of hexapeptide of ADP,arachidonic acid and thrombin,were 8.91 × 10-8 mol.L-1,9.33 × 10-8 mol.L-1 and 4.17 × 10-6 mol.L-1,respectively.The anti-aggregation IC 50 of eptifibatide induced by ADP was 1.00 × 10-7 mol.L-1.CONCLUSION Hexapeptide has the effect of anti-platelet aggregation in human in vitro.